PGHLPharmaceuticals
Procter & Gamble Health Ltd — PE Ratio & Valuation Analysis
₹4798.80
-1.61%
Current P/E31.44xPrice to earnings
Industry P/E31.77xSector average
4Y Avg P/E40.8x22.9% below avg
✅
1.0% Discount to Industry
PGHL P/E 31.44x vs sector avg 31.77x
📊
Historical PE Ratio
| Year | EPS (₹) | Year-end Price | PE Ratio |
|---|---|---|---|
| 2024 | ₹121.00 | ₹5238 | 43.3x |
| 2023 | ₹138.00 | ₹4948 | 35.9x |
| 2022 | ₹115.98 | ₹3953 | 34.1x |
| 2021 | ₹107.00 | ₹5338 | 49.9x |
PE = Year-end closing price ÷ Diluted EPS. Source: NSE/BSE filings.
💡
Understanding Procter & Gamble Health Ltd Valuation
Procter & Gamble Health Ltd (PGHL) currently trades at 31.44x earnings. The Pharmaceuticals sector average PE is 31.77x. PGHL is trading at a discount to peers — may indicate relative value. Historically, PGHL has traded at an average PE of 40.8x — it is currently below that level. Always evaluate PE alongside earnings growth (PEG ratio), return on equity, debt levels and business quality. A lower PE isn't always better. Educational data only — not investment advice.
ROE
36.42%
Dividend Yield
2.15%
More on Procter & Gamble Health Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.